Table 1 Major characteristics of the participants.
Cohorts | Sample types | Groups | Sample numbers | Age, years [median (min–max)] | Sex (male/female) | HBsAg (positive/negative) | HCV antibody (positive/negative) | BCLC (A/B/C/–) |
|---|---|---|---|---|---|---|---|---|
DSC (n = 10) | Tissue | HCC | 10 | 53 (39–65) | 9/1 | 10/0 | 0/10 | 7/1/2/0 |
TVC (n = 5) | HCC | 5 | 53 (42–57) | 5/0 | 5/0 | 0/5 | 5/0/0/0 | |
SVC1 (n = 24) | Serum | NC | 8 | 42 (37–54) | 7/1 | 0/8 | 0/8 | – |
LC | 8 | 40 (35–50) | 8/0 | 8/0 | 0/8 | – | ||
HCC | 8 | 53 (46–62) | 7/1 | 8/0 | 0/8 | 3/2/1/2 | ||
SVC2 (n = 40) | NC | 16 | 44 (36–55) | 14/2 | 0/16 | 0/16 | – | |
LC | 16 | 41 (34–51) | 13/3 | 16/0 | 0/16 | – | ||
HCC | 8 | 53 (47–63) | 6/2 | 8/0 | 0/8 | 2/2/3/1 | ||
FUC (n = 21) | HCC | 21 | 59 (20–78) | 17/4 | 21/0 | 0/21 | 5/14/2/0 | |
Pa | – | 0.08 | 0.17 | – | – | < 0.01 | ||
